https://european-biotechnology.net/wp-content/uploads/2026/02/Photo-credits-Karolina-Grabowska-on-Pexels-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-04 14:46:512026-02-04 14:46:51Cereno widens clinical program as competition heats up in lung disease
https://european-biotechnology.net/wp-content/uploads/2026/02/pexels-traf-3105062.jpg427640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-03 15:12:412026-02-03 15:12:41Poxel takes first step in recovery plan with €5 million equity line
https://european-biotechnology.net/wp-content/uploads/2026/02/headquarters-in-goettingen-data.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-03 08:24:552026-02-03 08:24:55Sartorius returns to a path of profitable growth in 2025
https://european-biotechnology.net/wp-content/uploads/2026/02/jacky-nelson-VnH18Q1WWBQ-unsplash.jpg412640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-02 16:03:052026-02-02 16:03:05Kahimmune launches and secures exclusive license for dark-genome cancer vaccine platform
https://european-biotechnology.net/wp-content/uploads/2026/02/carolina-garcia-tavizon-2lRdRHh8wNc-unsplash-1030x688-1.jpg6881030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-02 11:37:532026-02-02 11:37:53Origami and Ipsen join forces on protein degradation in neuroscience
https://european-biotechnology.net/wp-content/uploads/2026/01/Lonza_Teaser_EBM.png540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-30 13:22:022026-01-30 13:22:02CDMOs dominate the headlines – and Lonza delivers a clear message of strength
https://european-biotechnology.net/wp-content/uploads/2026/01/eb_2019_vetter_Particle-analysis.jpeg394700Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-30 10:45:372026-01-30 10:45:37Vetter: a multi-million-euro investment for new CDMO facility boost for Saarland/Germany
https://european-biotechnology.net/wp-content/uploads/2026/01/960-x-540-adc.jpeg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-29 16:01:572026-01-29 17:32:02After a turbulent phase: a new milestone from Takeda for Heidelberg Pharma
https://european-biotechnology.net/wp-content/uploads/2026/01/towfiqu-barbhuiya-6F2mPewg2RA-unsplash-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-29 12:26:222026-01-29 12:26:22Tenpoint wins FDA approval for presbyopia eye drop and raises $235 million
